North America Diabetic Assays Market Share, CAGR Analysis, and Strategic Roadmap 2032
The North America diabetic assays market was valued at USD 1.27 billion in 2024 and is projected to reach USD 1.85 billion by 2032. The market is expected to grow at a compound annual growth rate (CAGR) of 4.80% during the forecast period from 2025 to 2032. The U.S. dominates the market with the largest revenue share of 39.6% in 2024,...
0 Commenti 0 condivisioni 4 Views 0 Anteprima